economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

Fabrication

Sri Ramakrishna Hospital Drives Awareness of Rheumatic Disease, Emphasizing the Significance of Early Diagnosis and Lifestyle Changes ramkrishnalogo.JPG

Sri Ramakrishna Hospital Drives Awareness of Rheumatic Disease, Emphasizing the Significance of Early Diagnosis and Lifestyle Changes

creativebharatgroup@gmail.com December 28, 2024
Sri Ramakrishna Hospital took a proactive approach to combat the rising prevalence of rheumatic disease by...
Read More Read more about Sri Ramakrishna Hospital Drives Awareness of Rheumatic Disease, Emphasizing the Significance of Early Diagnosis and Lifestyle Changes
Dr. Rasha Kelej & First Ladies of African & Asia Called for 2025 Action to Build Healthcare and Media Capacity, Break Infertility Stigma & Support Girl Education During Merck Foundation Africa Asia Luminary in Tanzania OG_Multimedialog_93007.jpg

Dr. Rasha Kelej & First Ladies of African & Asia Called for 2025 Action to Build Healthcare and Media Capacity, Break Infertility Stigma & Support Girl Education During Merck Foundation Africa Asia Luminary in Tanzania

creativebharatgroup@gmail.com December 27, 2024
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 11th Edition of their annual...
Read More Read more about Dr. Rasha Kelej & First Ladies of African & Asia Called for 2025 Action to Build Healthcare and Media Capacity, Break Infertility Stigma & Support Girl Education During Merck Foundation Africa Asia Luminary in Tanzania
Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia OG_NewsReleaseCompanyLogo_93006.jpg

Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia

creativebharatgroup@gmail.com December 27, 2024
Osaka, Japan & Cambridge, Mass., United States:   HYQVIA [Immune Globulin Infusion...
Read More Read more about Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia